This month, Violaine and the team reveal the results of an exploratory study that looked at the effects of cannabidiol (CBD) on cortisol (a biomarker of stress) and anxiety symptoms in people who use cocaine. 78 participants with moderate to severe cocaine use disorder participated in the study. They were randomly separated into two groups, receiving a large dose (800 mg) of CBD or a placebo daily for 92 days. The results showed that compared to placebo, CBD was unfortunately not effective in reducing anxiety and cortisol levels in people who use cocaine. You can read the article that will be published shortly in the Journal of Addiction Medicine.
Only a few days left before the holiday season! On behalf of the entire research team of our laboratory, we would like to wish you and your loved ones, our best wishes for happiness, health and prosperity for the new year!